A SaaS platform that automates partner lab onboarding, tracks diagnostic kit inventory in real-time, monitors quality metrics and turnaround times, manages regulatory documentation per site, and provides unified analytics. Ensures consistent performance across all labs while integrating with existing LIS/EHR systems.

With MYNZ targeting Q4 2025 US feasibility and 2026 pivotal PMA for ColoAlert across 150 sites, plus competitors like Shield and Cologuard scaling rapidly, decentralized diagnostics need operational infrastructure now. Manual management can't support the data demands of FDA and CMS for distributed screening programs.